There have been 25 recent insider transactions recorded for Enlivex Therapeutics Ltd. (ENLV), including 2 buys and 1 sell. Total insider buying was valued at $30K and total insider selling at $156.76K.
Notable insiders with recent activity include Novik Shai A, Pomerantz Roger, Hart Gili. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — ENLV
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-03-18 |
Novik Shai A |
Director |
Unknown |
- |
- |
- |
6,974,017 |
| 2026-03-18 |
Pomerantz Roger |
Director |
Unknown |
150,000 |
$5.97 |
$895.05K |
- |
| 2026-03-18 |
Hart Gili |
Director |
Unknown |
3,382 |
$5.34 |
$18.06K |
- |
| 2026-03-18 |
Havron Avraham |
Director |
Unknown |
3,382 |
$5.34 |
$18.06K |
- |
| 2026-03-18 |
Shlosberger Shachar |
Chief Financial Officer |
Unknown |
- |
- |
- |
139,314 |
| 2026-03-18 |
Hershkovitz Oren |
Chief Executive Officer |
Unknown |
- |
- |
- |
172,855 |
| 2026-03-18 |
Galamidi Einat |
Chief Medical Officer |
Unknown |
- |
- |
- |
156,304 |
| 2025-11-24 |
Shlosberger Shachar |
Chief Financial Officer |
Unknown |
7,500 |
$5.34 |
$40.05K |
- |
| 2025-11-24 |
Hershkovitz Oren |
Chief Executive Officer |
Unknown |
60,000 |
$5.34 |
$320.4K |
- |
| 2025-11-24 |
Galamidi Einat |
Chief Medical Officer |
Unknown |
10,000 |
$3.21 |
$32.1K |
- |
| 2025-11-17 |
Novik Shai A |
Director |
Unknown |
250,000 |
$5.34 |
$1.34M |
- |
| 2024-05-28 |
Novik Shai A |
Director |
Unknown |
250,000 |
$12.23 |
$3.06M |
- |
| 2024-03-30 |
Shlosberger Shachar |
Chief Financial Officer |
Unknown |
5,000 |
$4.68 |
$23.4K |
- |
| 2023-11-16 |
Hershkovitz Oren |
Chief Executive Officer |
Unknown |
150,000 |
$8.19 |
$1.23M |
- |
| 2023-05-03 |
Novik Shai A |
Director |
Unknown |
250,000 |
$3.66 |
$915K |
- |
| 2022-12-10 |
Shlosberger Shachar |
Chief Financial Officer |
Unknown |
1,452 |
$10.12 |
$14.69K |
- |
| 2021-12-12 |
Novik Shai A |
Director |
Unknown |
145,237 |
$6.22 |
$903.37K |
- |
| 2021-12-12 |
Shlosberger Shachar |
Chief Financial Officer |
Unknown |
1,452 |
$6.22 |
$9.03K |
- |
| 2021-03-07 |
Shlosberger Shachar |
Chief Financial Officer |
Unknown |
1,452 |
$2.69 |
$3.91K |
- |
| 2019-06-01 |
Novik Shai A |
Director |
Unknown |
132,979 |
$2.69 |
$357.71K |
- |
| 2019-06-01 |
Hart Gili |
Director |
Unknown |
66,489 |
$2.69 |
$178.86K |
- |
| 2019-06-01 |
Havron Avraham |
Director |
Unknown |
53,192 |
$2.69 |
$143.09K |
- |
| 2015-10-09 |
Murray Michael Anthony |
Other: Former SVP - Operations |
Informative Sell |
56,390 |
$2.78 |
$156.76K |
- |
| 2008-01-02 |
Raney Dennis R |
Director |
RSU Award |
12,000 |
$1.25 |
$15K |
98,000 |
| 2008-01-02 |
Weatherson Harvey D |
Director |
RSU Award |
12,000 |
$1.25 |
$15K |
44,000 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
